On this page

Bexsero

Meningococcal Group B Vaccine

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Bexsero
Proper name
Meningococcal Group B Vaccine
Licence type
351(a)
BLA number
125546
Applicant
GlaxoSmithKline Biologicals
Center
CBER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
0.5ML Injection Intramuscular Pre-Filled Syringe Rx January 23, 2015

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity